Collaboration to improve the quality of in vivo antibiotics testing
New antibiotics are crucial in the fight against antimicrobial resistance. Assessing the effectiveness of new antibiotics requires standardised high-quality infection models, readily available to stakeholders developing new antibacterial treatments. The Innovative Medicines Initiative project COMBINE is developing a standardised in vivo pneumonia model to test small molecule antibiotics. This model is now being evaluated through a unique collaboration with some of the main actors in the field: CARB-X & CAIRD, iiCON and Pharmacology Discovery Services.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!